Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Imatinib-mesylate for all patients with hypereosinophilic syndrome?
Musto P, Perla G, Minervini MM, Carella AM, Coco FL, Catalano G. Musto P, et al. Among authors: minervini mm. Leuk Res. 2004 Jul;28(7):773-4. doi: 10.1016/j.leukres.2003.11.014. Leuk Res. 2004. PMID: 15158099 Free article. No abstract available.
Heterogeneity of response to imatinib-mesylate (glivec) in patients with hypereosinophilic syndrome: implications for dosing and pathogenesis.
Musto P, Falcone A, Sanpaolo G, Bodenizza C, Perla G, Minervini MM, Cascavilla N, Dell'Olio M, La Sala A, Mantuano S, Melillo L, Nobile M, Scalzulli PR, Bisceglia M, Carella AM. Musto P, et al. Among authors: minervini mm. Leuk Lymphoma. 2004 Jun;45(6):1219-22. doi: 10.1080/10428190310001641143. Leuk Lymphoma. 2004. PMID: 15360005
Combination treatment of flag with non-pegylated liposomal doxorubicin (MYOCET(TM)) in elderly patients with acute myeloid leukemia: a single center experience.
Melillo L, Valente D, D'Arena G, Dell'Olio M, Falcone A, Minervini MM, Nobile M, Rossi G, Sanpaolo G, Scalzulli PR, Cascavilla N. Melillo L, et al. Among authors: minervini mm. Int J Immunopathol Pharmacol. 2011 Jul-Sep;24(3):703-9. doi: 10.1177/039463201102400316. Int J Immunopathol Pharmacol. 2011. PMID: 21978702 Free article.
Optimal time-points for minimal residual disease monitoring change on the basis of the method used in patients with acute myeloid leukemia who underwent allogeneic stem cell transplantation: a comparison between multiparameter flow cytometry and Wilms' tumor 1 expression.
Rossi G, Carella AM, Minervini MM, di Nardo F, Waure Cd, Greco MM, Merla E, Cillis GP, Di Renzo N, Melpignano A, Capalbo S, Palumbo G, Pisapia G, Cascavilla N. Rossi G, et al. Among authors: minervini mm. Leuk Res. 2015 Feb;39(2):138-43. doi: 10.1016/j.leukres.2014.11.011. Epub 2014 Nov 29. Leuk Res. 2015. PMID: 25498507
41 results